FDA accelerates Diamid immunotherapy for type 1 diabetes management
Diamyd is an antigen-specific immunotherapy that preserves insulin-producing beta cells. Image credit: Image Point Fr / Shutterstock. Swedish biotech Diamyd has received Fast Track designation from the US Food and…